FDA product code DGQ: Whole Blood Plasma, Antigen, Antiserum, Control

DGQ is the FDA product code for whole blood plasma, antigen, antiserum, control. It is a Class I device, regulated under 21 CFR 866.5700 and reviewed by the Hematology panel. FDA has cleared 1 510(k) submission under DGQ. The average 510(k) review took 99 days (median 99).

Classification

FieldValue
Device nameWhole Blood Plasma, Antigen, Antiserum, Control
Device classClass I
Regulation21 CFR 866.5700
Review panelHE — Hematology
Medical specialtyImmunology
Premarket route510(k) exempt

Compare with all 510(k) review times · Search every DGQ clearance

Top DGQ applicants

ApplicantClearancesLatest
Diagnostica, Inc.11979-10-17

Most recent DGQ clearances

510(k)ApplicantDeviceDecision dateReview days
K791282Diagnostica, Inc.ANTI-HUMAN SERUM1979-10-1799

Recalls for DGQ devices

FDA recall records list no recalls for product code DGQ.

Frequently asked questions

What is FDA product code DGQ?

DGQ is the FDA product code for whole blood plasma, antigen, antiserum, control. It is a Class I device, regulated under 21 CFR 866.5700 and reviewed by the Hematology panel.

What device class is DGQ?

Class I, regulation 21 CFR 866.5700. Typical premarket route: 510(k) exempt.

How long does a 510(k) take for product code DGQ?

Across 1 cleared submissions the average was 99 days from receipt to decision (median 99).

Which companies have the most DGQ clearances?

Diagnostica, Inc. (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times